Anticancer Therapies – Webinars and Online Events

On June 28-29 join us for an insightful two-day online event featuring renowned experts who will share their innovative work in cancer research. Don't miss out on this opportunity to stay up-to-date on the latest developments in these fields and network with fellow professionals.

This inaugural event will showcase recent advances in the development of cell and gene therapies and the opportunities they provide for the treatment of disease and injury. Focus will be given to cancer immunotherapies and vaccines, stem cells, vector technologies and examples of genetic modification to treat a range of conditions.

Speaking at The Landscape of Cancer Research 2022, Nicholas Abuid, PhD from ACROBiosystems, presented his talk on providing high purity, customizable, and bioactive reagents to support research and translation in cancer immune therapy. Their catalogue ranges in targets for various diseases.

Do you want to bring your CAR T-cell research into clinical applications?

Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR T-cell therapies – from basic research to process development and clinical manufacturing. Discover the products, tools and services that build on Miltenyi Biotec’s expertise to move your CAR T-cell projects forward.

Combining both real-time live-cell imaging with biosensor-based impedance measurements is now possible for the first time, providing a multi-parametric, information-rich cellular analysis.

Returning for a second year, this online event will provide researchers with a unique opportunity to hear about the advances taking place within cancer research. We will bring together a broad cross-section of experts to share their work in areas such as omics, immunology, drug discovery and cell science.

In this webinar you will learn how the power of large-scale proteomics can be leveraged for multiple divergent applications in the field of oncology.

Cell-based chimeric antigen receptor (CAR) T cell therapies have rapidly advanced in recent years, with a variety of targets in clinical research and several FDA approved products already on the market.

Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to attack cancer cells, but manufacturing these cells represents a major challenge for the industry.

In this webinar, Dr George Poulogiannis from The Institute of Cancer Research, will discuss the relationship between oncogenic signaling and metabolic rewiring and explore cutting-edge technologies that can be used to track metabolism.